Detalhe da pesquisa
1.
DEBIRI plus capecitabine: a treatment option for refractory liver-dominant metastases from colorectal cancer.
Future Oncol
; 15(20): 2349-2360, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28440086
2.
Survival outcome of tyrosine kinase inhibitors beyond progression in association to radiotherapy in oligoprogressive EGFR-mutant non-small-cell lung cancer.
Future Oncol
; 15(33): 3775-3782, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31709807
3.
Anastrozole-related acute hepatitis with autoimmune features: a case report.
BMC Gastroenterol
; 11: 32, 2011 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-21453541
4.
Impact of Exon 19 Deletion Subtypes in EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer Treated With First-Line Tyrosine Kinase Inhibitors.
Clin Lung Cancer
; 20(2): 82-87, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30473385
5.
Clinical staging of malignant pleural mesothelioma: current perspectives.
Lung Cancer (Auckl)
; 8: 127-139, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28860886
6.
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study.
Mol Diagn Ther
; 20(1): 65-74, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26610798
7.
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis.
Mol Diagn Ther
; 20(1): 55-63, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26645830
8.
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases: A Retrospective, STROBE-Compliant, Single-Center Study Comparing Chemotherapy Alone and Combination Chemotherapy With Cetuximab or Bevacizumab.
Medicine (Baltimore)
; 95(20): e3722, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27196492
9.
Hormone Receptor Status and HER2 Expression in Primary Breast Cancer Compared With Synchronous Axillary Metastases or Recurrent Metastatic Disease.
Clin Breast Cancer
; 15(5): 307-12, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25922284
10.
Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study.
Cardiovasc Intervent Radiol
; 38(6): 1523-31, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25799948